PEPG Q3 2025 Earnings — PepGen Inc. Revenue & Financial Results | Market Cap Arena

PEPGPepGen Inc.

$435M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$339,000

Operating Income

-$19M

Net Income

-$18M

EPS (Diluted)

$-0.52

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$190M

Total Liabilities

$27M

Stockholders' Equity

$163M

Cash & Equivalents

$143M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$339,000	$0	—
Operating Income	-$19M	-$23M	+19.5%
Net Income	-$18M	-$21M	+15.7%